FDA Moves to Ease Access to Unproven Peptides, Despite Staff Safety Concerns

Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration is moving forward with plans to ease access to unproven peptide drugs that are popular among members of Kennedy's Make America Healthy Again movement. Ars Technica reports that FDA staff scientists found the drugs have not been sufficiently studied to establish safety and efficacy and may cause harms.